Q1 EPS Estimate for Fennec Pharmaceuticals Lifted by Analyst
Fennec Pharmaceuticals Inc. (TSE:FRX – Free Report) – Equities research analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a research report issued to clients and investors on Monday, March 10th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will post earnings of ($0.14) per share for […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Free Report) – Equities research analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a research report issued to clients and investors on Monday, March 10th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will post earnings of ($0.14) per share for […]
